QI
HAE icon

Qtron Investments’s Haemonetics HAE Stock Holding History

Qtron Investments’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,725
Closed -$225K – 446
2024
Q2 		$225K Sell
2,725
-3,585
-57% -$315K 0.03% 434
2024
Q1 		$539K Hold
6,310
– – 0.08% 328
2023
Q4 		$540K Buy
6,310
+343
+6% +$29.7K 0.09% 312
2023
Q3 		$535K Buy
5,967
+1,168
+24% +$104K 0.1% 275
2023
Q2 		$409K Buy
4,799
+733
+18% +$62K 0.08% 310
2023
Q1 		$336K Buy
4,066
+1,351
+50% +$109K 0.07% 341
2022
Q4 		$214K Hold
2,715
– – 0.04% 396
2022
Q3 		$201K Buy
+2,715
New +$195K 0.05% 397
2019
Q1 		– Sell
-2,740
Closed -$274K – 213
2018
Q4 		$274K Buy
+2,740
New +$288K 0.21% 110

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Qtron Investments's HAE Position: Q3 2024 in Review

Qtron Investments sold out of Haemonetics (HAE) in Q3 2024, closing a stake of 2,725 shares — an estimated $225K sold.

Qtron Investments first reported a position in HAE in Q4 2018 and held it in 9 quarters. The position peaked at $540K in Q4 2023. 306 funds tracked by Wall St. Rank hold HAE as of Q3 2024.

  • Qtron Investments reported no remaining Haemonetics position as of Q3 2024 after selling out during the quarter.
  • Qtron Investments sold 2,725 Haemonetics shares in Q3 2024, an estimated $225K.
  • Qtron Investments first reported a position in Haemonetics in Q4 2018 and held it in 9 quarters.
  • Qtron Investments's Haemonetics position peaked at $540K in Q4 2023.
  • 306 funds tracked by Wall St. Rank held Haemonetics as of Q3 2024.

Based on Qtron Investments's 13F filing for Q3 2024, filed 13 Nov 2024.